Faculty profile
Frédéric Pouliot
Back to facultyResearch
Read how they describe their research on their Université Laval profile.
Latest funding
Harnessing the gut microbiome-prostate cancer crosstalk to discover predictive biomarkers of risk and potential preventive strategies
CIHR · 2025 · Co-investigator
- $2,487,015
TRIPLE-SWITCH: A Randomized Clinical Trial for the Addition of Docetaxel to Androgen Receptor Pathway Inhibitors (ARPI) and Androgen Deprivation Treatment (ADT) in Patients with Metastatic Castration-Sensitive Prostate Cancer (mCSPC) and Suboptimal PSA Response.
CIHR · 2024 · Co-investigator
- $2,400,000
Establishment of the Innovative Cancer Engineering (ICE) facility
CFI · 2023 · Co-investigator
No publications available.
Harnessing the gut microbiome-prostate cancer crosstalk to discover predictive biomarkers of risk and potential preventive strategies
Principal investigators: Fradet, Vincent; Isabel, Sandra; Labbé, David
Keywords: Avatar Mouse Models; Biomarkers; Genetically Engineered Mouse Models Of Prostate Cancer; Gut Microbiota; Lifestyle Habits; Metagenomics; Observational Study; Prebiotics; Probiotics; Prostate Cancer Risk
TRIPLE-SWITCH: A Randomized Clinical Trial for the Addition of Docetaxel to Androgen Receptor Pathway Inhibitors (ARPI) and Androgen Deprivation Treatment (ADT) in Patients with Metastatic Castration-Sensitive Prostate Cancer (mCSPC) and Suboptimal PSA Response.
Principal investigators: Ong, Michael; Jafri, mariam
Keywords: Androgen Deprivation Treatment (Adt); Androgen Receptor Pathway Inhibitors (Arpi); Circulating Tumour Dna (Ctdna); Docetaxel; International; Metastatic Castration-Sensitive Prostate Cancer; Prostate Specific Antigen (Psa); Randomized Controlled Trial
Establishment of the Innovative Cancer Engineering (ICE) facility
Principal investigators: Stéphane Bolduc, Bordeleau Francois
Keywords: 3D biomimetic tissue models, precision oncology, oncology Rheology, biofabrication, large particle sorter, deep tissue 3D imaging systems
Understanding mitochondrial metabolism to identify prostate cancer metabolic vulnerabilities
Principal investigators: Audet-Walsh, Étienne
Keywords: Androgen Receptor; Citrate; Metabolic Vulnerability; Metabolomics; Mitochondria; Organoids; Prostate Cancer; Steroids; Tca Cycle
Radiopharmaceutical laboratory equipment for innovative theranostics and molecular imaging
Principal investigators: Beauregard, Jean-Mathieu
Keywords: Theranostics, Molecular Imaging, Nuclear Medicine, Radiochemistry, Radiopharmaceuticals, Positron Emission Tomography, Radiopharmaceutical Therapy Radiosynthesis Unit, HPLC, Dose Calibrator
Towards Personalized Dosimetry-Based Radioligand Therapy of Prostate Cancer as a New Standard of Practice
Principal investigators: Beauregard, Jean-Mathieu; Després, Philippe; Rahmim, Arman; Uribe, Carlos F
Keywords: Artificial Intelligence; Dosimetry; Gpu Computing; Molecular Imaging; Personalized Medicine; Position Emission Tomography; Predictive/Prognostic Biomarkers; Quantitative Spect; Radioligand Therapy; Theranostics
Towards optimization of anti-hormonal therapy in advanced prostate cancer
Principal investigators: Guillemette, Chantal; Levesque, Eric
Keywords: Anti-Androgens; Drug Metabolism; Metabolomics; Pharmacogenomics; Predictive Markers; Prostate Cancer; Steroids
Chercheurs-boursiers cliniciens
Principal investigators: Pouliot, Frédéric
Keywords: CANCER DE LA PROSTATE, SINGLE CELL ANALYSES, TOMOGRAPHIE PAR EMISSION DE POSITRON, MICROSCOPIE BIOLUMINESCENCE, IMAGERIE, MODELES CELLULAIRES ET CULTURE PRIMAIRE; Cancer; Cancer de l'appareil urinaire; Imagerie
Chercheurs-boursiers cliniciens
Principal investigators: POULIOT, FRÉDÉRIC
Keywords: Cancer de la prostate // Imagerie moléculaire // Transcription génomique // Cellules tumorales circulantes // Immunothérapie // Culture primaire; Cancer; Diagnostic et détection du cancer; Cancer de la prostate
Development of integrative multigenic molecular imaging methods to detect cancers in vivo and in vitro
Principal investigators: Pouliot, Frederic
Keywords: Prostate cancer, detection and diagnostic, molecular imaging, PCA3/DD3, Mouse model In vivo and in vitro imaging system, cell bioluminescence miscroscopy
From public funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998 with their latest competition results, the Canada Foundation for Innovation, Genome Canada, the Canadian Space Agency, Canada Research Chairs, the Fonds de recherche du Québec, Ontario research funding, Michael Smith Health Research BC, the Canadian Cancer Society, Heart & Stroke and Brain Canada.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.
Profile data last refreshed on September 29, 2026 from the university directory, publication records and public research funding records.